Research Article | Open Access
Anti-Inflammatory Effects of Flavonoids: Genistein, Kaempferol, Quercetin, and Daidzein Inhibit STAT-1 and NF-B Activations, Whereas Flavone, Isorhamnetin, Naringenin, and Pelargonidin Inhibit only NF-B Activation along with Their Inhibitory Effect on iNOS Expression and NO Production in Activated Macrophages
In inflammation, bacterial products and proinflammatory cytokines induce the formation of large amounts of nitric oxide (NO) by inducible nitric oxide synthase (iNOS), and compounds that inhibit NO production have anti-inflammatory effects. In the present study, we systematically investigated the effects of 36 naturally occurring flavonoids and related compounds on NO production in macrophages exposed to an inflammatory stimulus (lipopolysaccharide, LPS), and evaluated the mechanisms of action of the effective compounds. Flavone, the isoflavones daidzein and genistein, the flavonols isorhamnetin, kaempferol and quercetin, the flavanone naringenin, and the anthocyanin pelargonidin inhibited iNOS protein and mRNA expression and also NO production in a dose-dependent manner. All eight active compounds inhibited the activation of nuclear factor-B (NF-B), which is a significant transcription factor for iNOS. Genistein, kaempferol, quercetin, and daidzein also inhibited the activation of the signal transducer and activator of transcription 1 (STAT-1), another important transcription factor for iNOS. The present study characterises the effects and mechanisms of naturally occurring phenolic compounds on iNOS expression and NO production in activated macrophages. The results partially explain the pharmacological efficacy of flavonoids as anti-inflammatory compounds.
- R. G. Knowles and S. Moncada, “Nitric oxide synthases in mammals,” Biochemical Journal, vol. 298, part 2, pp. 249–258, 1994.
- W. K. Alderton, C. E. Cooper, and R. G. Knowles, “Nitric oxide synthases: structure, function and inhibition,” Biochemical Journal, vol. 357, part 3, pp. 593–615, 2001.
- R. Korhonen, A. Lahti, H. Kankaanranta, and E. Moilanen, “Nitric oxide production and signaling in inflammation,” Current Drug Targets, vol. 4, no. 4, pp. 471–479, 2005.
- E. Moilanen, B. J. R. Whittle, and S. Moncada, “Nitric oxide as a factor of inflammation,” in Inflammation: Basic Principles and Clinical Correlates, J. I. Gallin and R. Snyderman, Eds., pp. 787–801, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 1999.
- C. Bogdan, “Nitric oxide and the immune response,” Nature Immunology, vol. 2, no. 10, pp. 907–916, 2001.
- J. R. Connor, P. T. Manning, S. L. Settle et al., “Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase,” European Journal of Pharmacology, vol. 273, no. 1-2, pp. 15–24, 1995.
- J.-P. Pelletier, D. Jovanovic, J. C. Fernandes et al., “Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase,” Arthritis & Rheumatism, vol. 41, no. 7, pp. 1275–1286, 1998.
- S. M. Evans and B. J. R. Whittle, “Interactive roles of superoxide and inducible nitric oxide synthase in rat intestinal injury provoked by non-steroidal anti-inflammatory drugs,” European Journal of Pharmacology, vol. 429, no. 1–3, pp. 287–296, 2001.
- P. Vallance and J. Leiper, “Blocking NO synthesis: how, where and why?” Nature Reviews Drug Discovery, vol. 1, no. 12, pp. 939–950, 2002.
- E. Middleton Jr., C. Kandaswami, and T. C. Theoharides, “The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer,” Pharmacological Reviews, vol. 52, no. 4, pp. 673–751, 2000.
- B. H. Havsteen, “The biochemistry and medical significance of the flavonoids,” Pharmacology and Therapeutics, vol. 96, no. 2-3, pp. 67–202, 2002.
- Y.-L. Lin and J.-K. Lin, “(-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-B,” Molecular Pharmacology, vol. 52, no. 3, pp. 465–472, 1997.
- Y.-C. Liang, Y.-T. Huang, S.-H. Tsai, S.-Y. Lin-Shiau, C.-F. Chen, and J.-K. Lin, “Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages,” Carcinogenesis, vol. 20, no. 10, pp. 1945–1952, 1999.
- H. Kim, Y. S. Kim, S. Y. Kim, and K. Suk, “The plant flavonoid wogonin suppresses death of activated C6 rat glial cells by inhibiting nitric oxide production,” Neuroscience Letters, vol. 309, no. 1, pp. 67–71, 2001.
- L. C. Green, D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum, “Analysis of nitrate, nitrite, and nitrate in biological fluids,” Analytical Biochemistry, vol. 126, no. 1, pp. 131–138, 1982.
- A. Lahti, O. Sareila, H. Kankaanranta, and E. Moilanen, “Inhibition of p38 mitogen-activated protein kinase enhances c-Jun N-terminal kinase activity: implication in inducible nitric oxide synthase expression,” BMC Pharmacology, vol. 6, no. 1, p. 5, 2006.
- M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976.
- O. Sareila, R. Korhonen, O. Kärpänniemi, R. Nieminen, H. Kankaanranta, and E. Moilanen, “JAK inhibitors AG-490 and WHI-P154 decrease IFN--induced iNOS expression and NO production in macrophages,” Mediators of Inflammation, vol. 2006, no. 2, Article ID 16161, 7 pages, 2006.
- Q.-W. Xie, Y. Kashiwabara, and C. Nathan, “Role of transcription factor NF-B/Rel in induction of nitric oxide synthase,” Journal of Biological Chemistry, vol. 269, no. 7, pp. 4705–4708, 1994.
- J. Gao, D. C. Morrison, T. J. Parmely, S. W. Russell, and W. J. Murphy, “An interferon--activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon- and lipopolysaccharide,” Journal of Biological Chemistry, vol. 272, no. 2, pp. 1226–1230, 1997.
- H. Ruetten and C. Thiemermann, “Effects of tyrphostins and genistein on the circulatory failure and organ dysfunction caused by endotoxin in the rat: a possible role for protein tyrosine kinase,” British Journal of Pharmacology, vol. 122, no. 1, pp. 59–70, 1997.
- M. Mamani-Matsuda, T. Kauss, A. Al-Kharrat et al., “Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators,” Biochemical Pharmacology, vol. 72, no. 10, pp. 1304–1310, 2006.
- A. R. Kim, J. Y. Cho, Y. Zou, J. S. Choi, and H. Y. Chung, “Flavonoids differentially modulate nitric oxide production pathways in lipopolysaccharide-activated RAW264.7 cells,” Archives of Pharmacal Research, vol. 28, no. 3, pp. 297–304, 2005.
- H. Sadowska-Krowicka, E. E. Mannick, P. D. Oliver et al., “Genistein and gut inflammation: role of nitric oxide,” Proceedings of the Society for Experimental Biology and Medicine, vol. 217, no. 3, pp. 351–357, 1998.
- F. Sheu, H.-H. Lai, and G.-C. Yen, “Suppression effect of soy isoflavones on nitric oxide production in RAW 264.7 macrophages,” Journal of Agricultural and Food Chemistry, vol. 49, no. 4, pp. 1767–1772, 2001.
- J. Wang and G. Mazza, “Inhibitory effects of anthocyanins and other phenolic compounds on nitric oxide production in LPS/IFN--activated RAW 264.7 macrophages,” Journal of Agricultural and Food Chemistry, vol. 50, no. 4, pp. 850–857, 2002.
- L. S. Scuro, P. U. Simioni, D. L. Grabriel et al., “Suppression of nitric oxide production in mouse macrophages by soybean flavonoids accumulated in response to nitroprusside and fungal elicitation,” BMC Biochemistry, vol. 5, no. 1, p. 5, 2004.
- G. Autore, L. Rastrelli, M. R. Lauro et al., “Inhibition of nitric oxide synthase expression by a methanolic extract of Crescentia alata and its derived flavonols,” Life Sciences, vol. 70, no. 5, pp. 523–534, 2001.
- J.-C. Chen, F.-M. Ho, P.-D. L. Chao et al., “Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IB kinase, nuclear factor- B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia,” European Journal of Pharmacology, vol. 521, no. 1–3, pp. 9–20, 2005.
- T. Salonen, O. Sareila, U. Jalonen, H. Kankaanranta, R. Tuominen, and E. Moilanen, “Inhibition of classical PKC isoenzymes downregulates STAT1 activation and iNOS expression in LPS-treated murine J774 macrophages,” British Journal of Pharmacology, vol. 147, no. 7, pp. 790–799, 2006.
- H.-Y. Lin, S.-C. Shen, and Y.-C. Chen, “Anti-inflammatory effect of heme oxygenase 1: glycosylation and nitric oxide inhibition in macrophages,” Journal of Cellular Physiology, vol. 202, no. 2, pp. 579–590, 2005.
- Y. Takano-Ishikawa, M. Goto, and K. Yamaki, “Structure-activity relations of inhibitory effects of various flavonoids on lipopolysaccharide-induced prostaglandin production in rat peritoneal macrophages: comparison between subclasses of flavonoids,” Phytomedicine, vol. 13, no. 5, pp. 310–317, 2006.
- H. K. Kim, B. S. Cheon, Y. H. Kim, S. Y. Kim, and H. P. Kim, “Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships,” Biochemical Pharmacology, vol. 58, no. 5, pp. 759–765, 1999.
- G. M. Raso, R. Meli, G. Di Carlo, M. Pacilio, and R. Di Carlo, “Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1,” Life Sciences, vol. 68, no. 8, pp. 921–931, 2001.
- G. K. Rangan, Y. Wang, Y.-C. Tay, and D. C. Harris, “Inhibition of NFB activation with antioxidants is correlated with reduced cytokine transcription in PTC,” American Journal of Physiology, vol. 277, no. 5, part 2, pp. F779–F789, 1999.
- T. Akiyama, J. Ishida, S. Nakagawa et al., “Genistein, a specific inhibitor of tyrosine-specific protein kinases,” Journal of Biological Chemistry, vol. 262, no. 12, pp. 5592–5595, 1987.
Copyright © 2007 Mari Hämäläinen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.